Biobeat
PrivateLast Round
Series B
Dec 30, 2025
Total Funding Raised
$50M
Momentum Score
50 /100
Company Overview
Biobeat is a medical technology company that develops wearable remote patient monitoring devices designed to measure vital signs using wireless, non-invasive, and medical-grade technology.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Medical Devices, Medical AI, Sensors, Health IoT
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biobeat Comps
Public and private peers based on sector, stage, and business model.
Biobeat Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 30, 2025 |
Key People
Founding team and executive leadership
Biobeat Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ally Bridge Group | Series B |
| OrbiMed | Series B |
| Elevage Medical Technologies | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
First-of-its-kind cuffless 24-hour blood pressure monitoring system cleared by FDA.
- Dec 30, 2025
$50M round completed.
Biobeat Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Biobeat's valuation, stock price, and market status.
